Loading...
Market
U.S. Adult Calorie Intake Decrease by 5% by End of 2026?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
National Health and Nutrition Examination Survey (NHANES) or similar studies
Story
Surge in Wegovy, Zepbound Use to Reduce U.S. Calorie Intake by 10 Quadrillion by 2030
Oct 15, 2024, 01:00 AM
A surge in the use of GLP-1 drugs, including Wegovy and Zepbound, is projected to significantly reduce calorie intake in U.S. adults by 10 quadrillion by 2030, according to a new report. This increase in GLP-1 prescriptions for obesity has been observed alongside a relatively flat prescribing rate for GLP-1s labeled for type 2 diabetes between June and September 2024, as noted in Truveta Research's latest GLP-1 monitoring report.
View original story
Similar markets
Yes • 50%
No • 50%
Decrease by more than 10% • 25%
Decrease by 5-10% • 25%
No significant change • 25%
Increase • 25%
Reduce seed oils • 25%
Reduce sugar intake • 25%
Increase fiber intake • 25%
Other • 25%
Target HFCS only • 25%
Target cane sugar only • 25%
Target both HFCS and cane sugar • 25%
No targeted campaigns • 25%
Increase by more than 20% • 25%
Increase by 10-20% • 25%
Remain stable • 25%
Decrease • 25%
Sodium • 25%
Saturated Fat • 25%
Added Sugars • 25%
Other • 25%
WHO • 25%
CDC • 25%
Other national health organizations • 25%
No new regulations • 25%
Significant decrease • 25%
Moderate decrease • 25%
No change • 25%
Increase • 25%